Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyanation Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106631886B reveals a low-cost synthesis route for 2-nitro-4-trifluoromethyl benzonitriles using safe ferrocyanide salts and recyclable catalysts for scalable production.
Novel synthesis process for ethyl 2 3 dicyanopropionate offers high yield and reduced waste. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN112010918A details a novel cyanation route for 17-beta-hydroxy steroids, eliminating toxic mercury catalysts and enabling high-purity impurity reference standards for pharmaceutical quality control.
Patent CN105348160A reveals green Cartap production reducing wastewater. Offers cost reduction and supply reliability for agrochemical manufacturing partners.
Analysis of patent CN103435464B reveals high-purity diphenylethanone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104031063A reveals novel cyanation route for high-purity quinolone intermediates enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN114133323B reveals a safe TMSCN-based route for morphine precursors, offering significant yield improvements and cost reduction in API manufacturing.
Patent CN120117998A reveals cost-effective route for apalutamide intermediate ensuring supply chain stability and reduced manufacturing complexity for global buyers.
Patent CN102603566B details a room-temperature asymmetric synthesis of chiral amino nitriles using copper catalysis, offering mild conditions for pharmaceutical intermediate manufacturing.